HRD1-specific inhibitors have been recently identified24, and it will be interesting to further evaluate the therapeutic efficacy of HRD1-specific inhibitors for prevention or treatment of HFD-induced metabolic disorders. The gene discussed is SYVN1; the disease is Other metabolic disease.